Tag Archives: Social Impact Investment

Steps to Unfreeze the Glacial Pace of Dementia Research and Drugs Development (BBC News / Department of Health / Dementia Challenge / World Dementia Council)

Posted on June 19, 2014 by Dementia and Elderly Care News

Summary World Dementia Envoy, Dr Dennis Gillings, has commented on how progress on new research and treatments for dementia has been “achingly slow”. The World Dementia Council, led by the World Dementia Envoy, is meeting today; six months after the … Continue reading →

Posted in Acute Hospitals, Alzheimer's Society, Alzheimer’s Research UK, BBC News, Charitable Bodies, Commissioning, Community Care, Department of Health, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Integrated Care, International, Management of Condition, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Academia-Industry Partnerships, African Agricultural Capital Fund, Araclon, AstraZeneca, BBC Health News, Blackfriars Consensus Statement, Challenge on Dementia (David Cameron), Charitable Funding, Collaborative Projects, Cross-Sector Partnerships, Crowdsource Investment, Data Sharing, Defeat Dementia Campaign, Dementia Challenge, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dementia Time-Bomb, Dementia-Friendly Communities, Dennis Gillings: Former World Dementia Envoy, Diet, Diet and Dementia, Dietary Factors, Dr Etienne Hirsch: INSERM, Dr Linda Elam: Department of Health and Human Services (United States), Dr Neil Buckholtz: National Institute on Aging (NIA) and National Institutes of Health (NIH), Dr Paul Wicks: PatientsLikeMe, Dr Shekhar Saxena: Director of the Department of Mental Health and Substance Abuse at World Health Organization (WHO), Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Dr. Luc Truyen: Johnson&Johnson, Dr. Maria C. Carrillo: Alzheimer’s Association US, Dr. Yoshiki Niimi: Ministry of Health Labour and Welfare (Japan), DY Suharya: Alzheimer's Indonesia, Elisabetta Vaudano: Innovative Medicines Initiative, EU Joint Programme on Neurodegenerative Disease Research (JPND), Former Health Secretary Jeremy Hunt, G7 Global Dementia Summit, G8 Dementia Summit, G8 Dementia Summit Agreements, Gates Global Health Innovative Technology Fund, Genomics, Genomics in the NHS, George Vradenburg: President and Chairman of the Vradenburg Foundation and US Against Alzheimer’s, Global Action Against Dementia, Global Context, Global Dementia Legacy Event, Global Dementia Legacy Event on Finance and Social Investment, Global Dementia Legacy Event Speech (Dr Gillings), Global Digital Platform (for Dementia Research), Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Global Social Investment for Dementia, Gregory Simon: Polliwogg, GSK, Improving Care for People with Dementia, Incentives and Investment, Incentives for Drug Development, Innovation, Innovative Medicines Initiative (IMI), International Collaborations, International Programmes, IXICO, Janssen Research & Development, John Ryan: European Commission Public Health Directorate, Johnson & Johnson Innovation, Joint Programme on Neurodegenerative Disease Research (JPND), Jon Rouse: Department of Health, KHP/ LSHTM Centre for Global Mental Health: Kings College London, Kings College London, Layered Funding Models, Leadership, Legacies and Charitable Giving, Lifestyle Factors, Lifestyle Risk Factors, London School of Economics, Marc Wortmann: Executive Director of Alzheimer's Disease International (ADI), Market Failure, Market Failure (Dementia Research and Drug Development), Matthew Bishop: Author of Philanthrocapitalism, Medical Research Council (MRC), Medical Research Council's UK Dementias Research Platform (UKDP), MedImmune, Modifiable Risk Factors, Mr. Dirk Pilat: Directorate for Science, Mr. Mark Boleat: City of London, MRC UK Dementias Research Platform (UKDP), Ms Inez Jabalpurwala: Brain Canada Foundation, Ms. Cathrin Petty: JP Morgan, Openness and Collaboration, Orphan Diseases, Orphan Drug Act (United States), Partnership, Partnership and Collaboration, Partnership Working, Patent Box, Patents: Extended Period of Exclusivity, Payment Systems and Incentives, Philanthrocapitalism, Philanthropic Funding, Philanthropy, Policy Innovation, Prevention, Prime Minister’s Dementia Challenge, Professor Andrew Lo: MIT Sloan Professor of Finance, Professor Lefkos Middleton: Imperial College London, Professor Martin Knapp: Director of the Personal Social Services Research Unit at the London School of Economics and Political Science (LSE), Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Ronald Petersen: Mayo Alzheimer’s Disease Research Center, Promoting Brain Health (Blackfriars Consensus Statement), Public Health, Public-Private Partnership (PPP), Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Research and Innovation, Resource and Incentives, Risk Factors, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Entrepreneurs, Social Finance, Social Impact Bonds, Social Impact Investment, Social Investment, Social Media, SomaLogic, Stephen Johnston: Aging2.0 and Generator Ventures, Technology and Industry (OECD) & Technical Advisor to the World Dementia Council, Tom Wright CBE: Age UK, UK Dementias Research Platform, UK Dementias Research Platform (UKDP), UK Presidency of G8 2013, Use of Social Media, World Dementia Council | 1 Comment

Research Finance and Social Impact Investment: Global Dementia Event (Department of Health / Dementia Challenge / World Dementia Council)

Posted on June 17, 2014 by Dementia and Elderly Care News

Summary The first Global Dementia Legacy Event, following on from agreements made at the 2013 G8 Dementia Summit, is to be held on June 19th 2014 in London. International experts, including delegates from the World Health Organization, the OECD (Organisation … Continue reading →

Posted in Alzheimer’s Disease International (ADI), Charitable Bodies, Department of Health, Diagnosis, For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, National, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Quick Insights, Standards, UK, Universal Interest, World Health Organization (WHO) | Tagged Academia-Industry Partnerships, Challenge on Dementia (David Cameron), Charitable Funding, Collaborative Projects, Cross-Sector Partnerships, Crowdsource Investment, Data Sharing, Dementia Challenge, Dementia Diagnosis, Dementia Innovation, Dementia Research, Dennis Gillings: Former World Dementia Envoy, Dr Etienne Hirsch: INSERM, Dr Linda Elam: Department of Health and Human Services (United States), Dr Neil Buckholtz: National Institute on Aging (NIA) and National Institutes of Health (NIH), Dr Paul Wicks: PatientsLikeMe, Dr Shekhar Saxena: Director of the Department of Mental Health and Substance Abuse at World Health Organization (WHO), Dr Yves Joanette: Scientific Director of Canadian Institute of Health Research (Institute of Aging), Dr. Luc Truyen: Johnson&Johnson, Dr. Maria C. Carrillo: Alzheimer’s Association US, Dr. Yoshiki Niimi: Ministry of Health Labour and Welfare (Japan), DY Suharya: Alzheimer's Indonesia, Elisabetta Vaudano: Innovative Medicines Initiative, Former Health Secretary Jeremy Hunt, G8 Dementia Summit, G8 Dementia Summit Agreements, George Vradenburg: President and Chairman of the Vradenburg Foundation and US Against Alzheimer’s, Global Action Against Dementia, Global Context, Global Dementia Legacy Event, Global Envoy for Dementia Innovation, Global Leadership, Global Outlook, Gregory Simon: Polliwogg, Incentives and Investment, Innovation, Innovative Medicines Initiative (IMI), International Collaborations, International Programmes, John Ryan: European Commission Public Health Directorate, Jon Rouse: Department of Health, KHP/ LSHTM Centre for Global Mental Health: Kings College London, Kings College London, Leadership, Legacies and Charitable Giving, Marc Wortmann: Executive Director of Alzheimer's Disease International (ADI), Matthew Bishop: Author of Philanthrocapitalism, Mr. Dirk Pilat: Directorate for Science, Mr. Mark Boleat: City of London, Ms Inez Jabalpurwala: Brain Canada Foundation, Ms. Cathrin Petty: JP Morgan, Partnership, Partnership and Collaboration, Partnership Working, Payment Systems and Incentives, Philanthrocapitalism, Philanthropic Funding, Philanthropy, Policy Innovation, Prime Minister’s Dementia Challenge, Professor Andrew Lo: MIT Sloan Professor of Finance, Professor Lefkos Middleton: Imperial College London, Professor Martin Rossor: NIHR National Director for Dementia Research, Professor Ronald Petersen: Mayo Alzheimer’s Disease Research Center, Raj Long: Senior Regulatory Officer for Integrated Development in Global Health at the Bill & Melinda Gates Foundation, Research and Innovation, Resource and Incentives, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Impact Investment, Stephen Johnston: Aging2.0 and Generator Ventures, Technology and Industry (OECD) & Technical Advisor to the World Dementia Council, Tom Wright CBE: Age UK, World Dementia Council | Leave a comment

G8 Dementia Summit Programme (Dementia Challenge / Department of Health)

Posted on December 10, 2013 by Dementia and Elderly Care News

Summary The programme for the G8 Dementia Summit, to be held on December 11th 2013 in London, has been published. Read more: Programme for G8 Dementia Summit published. The Dementia Challenge. Full Text Link Reference G8 Dementia Summit Programme. (Provisional Summit Programme: 11 … Continue reading →

Posted in Department of Health, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Care Pathway, Pharmacological Treatments, Quick Insights, UK, Universal Interest | Tagged Delaying Dementia, Deputy Secretary General: OECD, European Commission, First G8 Dementia Summit, G8 Dementia Summit, G8 Ministers, G8 Nations, Global Context, Global Outlook, Improving Care for People with Dementia, International Collaborations, International Organisations, International Programmes, International Research, OECD, OECD Deputy Secretary-General, Organisation for Economic Co-operation and Development (OECD), Prevention, Prime Minister’s Dementia Challenge, Quality of Care, Quality of Care and Support, Quality of Care for People With Dementia, Quality of Life, Research and Development, Research and Innovation, Research Commitment, Research Mapping, Research Networks, Rt Hon Jeremy Hunt MP: Former Secretary of State for Health, Social Adaptation to Global Ageing and Dementia, Social Impact Investment, Translational Research, UK Presidency of G8 2013, UK Research Strengths in Dementia, WHO Director General, World Health Organisation (WHO) | Leave a comment

Tag Archives: Social Impact Investment

Steps to Unfreeze the Glacial Pace of Dementia Research and Drugs Development (BBC News / Department of Health / Dementia Challenge / World Dementia Council)

Research Finance and Social Impact Investment: Global Dementia Event (Department of Health / Dementia Challenge / World Dementia Council)

G8 Dementia Summit Programme (Dementia Challenge / Department of Health)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites